May, 2019

Article – “R&D for children’s antibiotics: a wake-up call” published in AMR Control

Tags: , , ,

We are delighted to see  an article on children’s antibiotics, co-authored by GARDP R&D Director, Dr Seamus O’Brien, Penta’s Chief Scientific Officer, Prof. Theo Zakoutlis and Prof. Mike Sharland, from St. George’s, University of London, published in AMR Control, as governments have been discussing AMR at the World Health Assembly.



Mar, 2019

GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR

Tags: , ,

Penta have joined forces with GARDP (The Global Antibiotic Research & Development Partnership) to tackle drug-resistant infections in children. Our strategic collaboration aims to accelerate paediatric development of antibiotic treatments including: clinical trials designed to meet regulatory requirements; and trials with a focus on public health interventions to inform treatment guidelines.



Feb, 2019

Penta representative makes first-time visits to neonatal units in Brazil

Tags: ,

Penta project manager Davide Bilardi, together with other NeoObs project partners, recently visited the neonatal units of the Santa Casa Hospital in São Paolo and the Clinical Research Unit of University of São Paolo in Ribeirao Preto. The visit occurred in the last week of January and was an opportunity to strengthen the relationship with new partner sites involved in the activities of this study.